| __timestamp | Amicus Therapeutics, Inc. | Takeda Pharmaceutical Company Limited |
|---|---|---|
| Wednesday, January 1, 2014 | 47624000 | 382096000000 |
| Thursday, January 1, 2015 | 76943000 | 345927000000 |
| Friday, January 1, 2016 | 104793000 | 312303000000 |
| Sunday, January 1, 2017 | 149310000 | 325441000000 |
| Monday, January 1, 2018 | 270902000 | 368298000000 |
| Tuesday, January 1, 2019 | 286378000 | 492381000000 |
| Wednesday, January 1, 2020 | 308443000 | 455833000000 |
| Friday, January 1, 2021 | 272049000 | 526087000000 |
| Saturday, January 1, 2022 | 276677000 | 633325000000 |
| Sunday, January 1, 2023 | 152381000 | 729924000000 |
| Monday, January 1, 2024 | 729924000000 |
Igniting the spark of knowledge
In the ever-evolving pharmaceutical landscape, research and development (R&D) are pivotal for innovation and growth. Over the past decade, Takeda Pharmaceutical Company Limited and Amicus Therapeutics, Inc. have demonstrated contrasting R&D investment strategies. Takeda, a global leader, has consistently allocated substantial resources, with a notable 90% increase in R&D expenses from 2014 to 2023. In contrast, Amicus, a smaller biotech firm, has shown a more modest growth of around 220% in the same period, reflecting its strategic focus on niche therapeutic areas.
While Takeda's R&D budget peaked in 2023, Amicus experienced a dip, highlighting the challenges smaller firms face in sustaining high investment levels. This comparison underscores the diverse approaches within the industry, where giants like Takeda leverage scale, and nimble players like Amicus navigate through focused innovation.
Who Prioritizes Innovation? R&D Spending Compared for Pfizer Inc. and Amicus Therapeutics, Inc.
Analyzing R&D Budgets: Zoetis Inc. vs Takeda Pharmaceutical Company Limited
R&D Spending Showdown: Takeda Pharmaceutical Company Limited vs United Therapeutics Corporation
R&D Insights: How Takeda Pharmaceutical Company Limited and Exelixis, Inc. Allocate Funds
Research and Development Expenses Breakdown: Takeda Pharmaceutical Company Limited vs Iovance Biotherapeutics, Inc.
Takeda Pharmaceutical Company Limited vs Ligand Pharmaceuticals Incorporated: Strategic Focus on R&D Spending
Takeda Pharmaceutical Company Limited or Taro Pharmaceutical Industries Ltd.: Who Invests More in Innovation?
Research and Development Investment: Takeda Pharmaceutical Company Limited vs BioCryst Pharmaceuticals, Inc.
Research and Development Expenses Breakdown: Neurocrine Biosciences, Inc. vs Amicus Therapeutics, Inc.
R&D Insights: How Jazz Pharmaceuticals plc and Amicus Therapeutics, Inc. Allocate Funds
Analyzing R&D Budgets: Grifols, S.A. vs Amicus Therapeutics, Inc.
Who Prioritizes Innovation? R&D Spending Compared for Amicus Therapeutics, Inc. and Soleno Therapeutics, Inc.